?Mito is the new keto? is a headline. Mitochondria are organelles.
A map of a noisy conversation, with C60 kept on its own card and inside its evidence.
Search interest now bundles NAD+, creatine, C60, and mitochondria as if they were flavors of one product. They are not. Mitochondria oxidize fuel to ATP. NAD+ is a cofactor those redox reactions use. Creatine buffers high-energy phosphate in muscle. C60 is a radical-reactive carbon cage sold in oil as an antioxidant adjunct.
This article is a seating chart. C60 oils occupy one chair. They do not become NAD+ or creatine by sharing a paragraph.
Why the bundle got loud
Midlife fatigue, ?biological age,? and podcast stacks pulled lab nouns into checkout carts. Keto trained the market to launch a Monday identity. ?Mito? is being asked to do the same thing. An eating pattern can start on Monday. An organelle cannot.
Professionals can use the trend as a teaching moment if they refuse the bundle.
Card 1 ? Mitochondria
Site of oxidative phosphorylation. Source and target of ROS. Human interventions that most reliably change muscle mitochondrial capacity are contractile (endurance and resistance work), plus the conditions that make training stick: sleep, protein, glycemic stability.
You cannot purchase a replacement set. You can stop treating ?mito? as a flavor.
Card 2 ? NAD+
Nicotinamide adenine dinucleotide, oxidized form. Required for dehydrogenase reactions that feed the electron-transport chain and for NAD+-dependent signaling (including sirtuin- and PARP-related repair talk). Tissue NAD+ status can shift with age and metabolic stress, which is why precursors (NR, NMN, and related compounds) became a category.
That category is not C60 and is not reviewed here as a shopping list. A reader whose real question is ?why am I empty?? still starts with sleep and muscle. Precursor use belongs in a clinician conversation, not in an automatic four-item cart.
Card 3 ? Creatine
A phosphate donor that regenerates ATP on short timescales in skeletal muscle and other high-demand tissues. Safety and performance data are comparatively mature. It is not an antioxidant sponge and not a mitochondrial vitamin. Hiding it inside a ?cellular stack? obscures the one ingredient with the dullest, strongest file.
Card 4 ? C60
Closed C60 cage. Documented radical-addition chemistry. C60 oils dissolve specified C60 in a named edible oil at a labeled serving.
Job on this table: candidate cleanup of extra oxidant load around tissues that make ATP?not cofactor replacement, not phosphagen buffering, not a stimulant.
Efficacy, reusable
Krusic et al. (1991): extensive radical chemistry. Gharbi et al. (2005): rodent antioxidant activity without acute or subacute toxicity in that model. Baati et al. (2012): longer median lifespan in rats given repeated oral C60 in olive oil, interpreted as lower age-associated oxidative stress. Small groups; not a human NAD+, creatine, or fatigue trial. Formulation and light can change C60?oil toxicology.
There is no large RCT showing C60 oil raises NAD+, replaces creatine, or ?turns on mitochondria? as a clinical endpoint. Steadier-day anecdotes are not assays.
Claim that survives review: C60 is a redox-active adjunct with chemical and animal support. It is not NAD+ therapy and not a mito drug.
How the cards may sit in one life?without becoming a stack
Engine room metaphor, used once: mitochondria are the room; NAD+ is part of the wiring language; creatine is a side battery for short loads; C60 is closer to a rag for extra sparks. Mopping is not rewiring. Rewiring talk is not a reason to skip sleep.
Order that stays defensible
Sleep, walking and strength, protein, morning light.
Creatine if the goal is muscle/phosphagen support and the user is an appropriate candidate.
Tested C60 oil if the sentence the user actually means is oxidative load.
NAD+ precursors only as a separate, informed decision.
Shop C60 does not need to win the table. It needs to remain a clean Card 4.
Safe use of that card
Identity. Pristine C60, stated purity, named carrier oil, concentration, third-party testing. Untested ?mito C60 NAD stacks? are a different object.
Do not self-start in pregnancy, lactation, childhood, unexplained systemic illness, active liver or kidney disease, or complex pharmacology?or as a substitute for evaluation of new severe fatigue.
If used. Label serving. With food if needed. Morning consistency beats stacking at 3 p.m. when stimulation would have been the honest tool. Store as directed; limit extra light. Review at 4?8 weeks. Stop for rash, breathing difficulty, unusual pain, or jaundice.
Do not publish. ?C60 boosts NAD+.? ?C60 is creatine for cells.? ?Mito in a spoon.? ?The new keto.?
Four sentences for retrieval
Mitochondria ? organelles that produce most ATP.
NAD+ ? cofactor in those redox reactions and in related signaling.
Creatine ? phosphagen buffer with a mature muscle-performance file.
C60 oil ? specified carbon-cage antioxidant in food oil (Shop C60).
Keto was a plate. Mito is anatomy. Keep the joke if you must. Do not build a cart on it.
C60 oils: Card 4 only?specified molecule, labeled serving, testing on file.
Education only. Not a prescription for a combined stack.
References
Amorim, J. A., et al. (2022). Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nature Reviews Endocrinology, 18(4), 243?258. https://doi.org/10.1038/s41574-021-00626-7
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119?141. https://doi.org/10.1038/s41580-020-00313-x
Kreider, R. B., et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation. Journal of the International Society of Sports Nutrition, 14, 18. https://doi.org/10.1186/s12970-017-0173-z
López-Otín, C., et al. (2013). The hallmarks of aging. Cell, 153(6), 1194?1217. https://doi.org/10.1016/j.cell.2013.05.039
Krusic, P. J., et al. (1991). Radical reactions of C60. Science, 254(5035), 1183?1185. https://doi.org/10.1126/science.254.5035.1183
Gharbi, N., et al. (2005). [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity in rodents. Nano Letters, 5(12), 2578?2585. https://doi.org/10.1021/nl051976y
Baati, T., et al. (2012). The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene. Biomaterials, 33(19), 4936?4946. https://doi.org/10.1016/j.biomaterials.2012.03.036